RecruitingNot ApplicableNCT07225894

PrEP (Pre-exposure Prophylaxis) Stigma and Women Ethnodrama Pilot Phase

Designing an Ethnodrama Addressing PrEP Stigma Toward Young Cisgender Women in Kenya


Sponsor

Duke University

Enrollment

160 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators will pilot test an ethnodrama intervention designed to transform community member beliefs about and foster support of young cisgender women (YCW) using Pre-exposure Prophylaxis (PrEP).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses community theater (called ethnodrama — plays written from real people's stories) to reduce the stigma around PrEP, a medication that helps prevent HIV infection. The goal is to see if watching these plays changes attitudes and reduces stigma for women who use or have used PrEP. **You may be eligible if...** - You are a young woman who currently uses or has previously used PrEP (HIV prevention medication) - You are a community member (adult woman or man) identified from the theater audience - You are an adult audience member who heard about the play and chose to attend **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEthnodrama Intervention

The intervention is six drama performances that are designed to transform community member beliefs about and foster support of young women's PrEP use, reduce PrEP-related enacted stigma toward young women, and reduce PrEP-related anticipated and internalized stigma among young women.


Locations(1)

Impact Research and Development

Kisumu, Kenya

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07225894


Related Trials